Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × fludarabine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Myelodysplastic Syndromes 22 Multiple Myeloma 17 Lymphoma 17 Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma, Non-Hodgkin 15 Lymphoma, Large B-Cell, Diffuse 15 Hematologic Neoplasms 15 Melanoma 10 Lymphoma, Follicular 10 Lymphoma, B-Cell 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia, Biphenotypic, Acute 10 Recurrence 9 Pancreatic Neoplasms 9 Lymphoma, Mantle-Cell 9 Neoplasms 8 Myeloproliferative Disorders 8 Lymphoma, B-Cell, Marginal Zone 8 Ovarian Neoplasms 7 Leukemia 7 Hodgkin Disease 7 Burkitt Lymphoma 7 Leukemia, Myelomonocytic, Chronic 6 Colorectal Neoplasms 5 Anemia, Refractory, with Excess of Blasts 5 Primary Myelofibrosis 4 Osteosarcoma 4 Neuroblastoma 4

Interventions

Specimen Handling 2 Sorafenib 2 Irinotecan 2 poly ICLC 1 pembrolizumab 1 durvalumab 1 dehydroftorafur 1 atezolizumab 1 Watchful Waiting 1 Vincristine 1 Platinum 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡